Maternal Supraphysiological Hypercholesterolemia Is Accompanied by Shifts in the Composition and Anti-Atherogenic Functions of Maternal HDL along with Maternal Cardiovascular Risk Markers at Term of Pregnancy
Background: Maternal physiological hypercholesterolemia (MPH) occurs in pregnancy for a proper fetal development. When cholesterol increases over the physiological range, maternal supraphysiological hypercholesterolemia (MSPH) is described, a condition underdiagnosed by a lack of evidence showing it...
Main Authors: | Claudette Cantin, Andrea Morales, Ramón Serra, Sebastián E. Illanes, Andrea Leiva |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-09-01
|
Series: | Antioxidants |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3921/12/10/1804 |
Similar Items
-
Increased Circulating Levels of PCSK9 and Pro-Atherogenic Lipoprotein Profile in Pregnant Women with Maternal Supraphysiological Hypercholesterolemia
by: Claudette Cantin, et al.
Published: (2022-04-01) -
Maternal supraphysiological hypercholesterolemia associates with endothelial dysfunction of the placental microvasculature
by: Bárbara Fuenzalida, et al.
Published: (2018-05-01) -
On the atherogenicity of triglyceride-rich lipoproteins and novel markers for the assessment of their atherogenic potentials
by: Alaupovic Petar
Published: (2002-07-01) -
Atherogenic Index of Plasma in the Three Trimesters of Pregnancy
by: Bana K. Hamadameen, et al.
Published: (2023-11-01) -
Effect of Aqueous Extract of Walnut Leaves on Lipid Profile and Atherogenic Ratio in Hypercholesterolemic Rats
by: Rabia Azhar, Arif Siddiqui, Shazia Ali
Published: (2015-09-01)